UBS maintains Linde at Buy, raises price target to $585 from $574

UBS kept its Buy rating on Linde and increased its price target to $585, up from $574. This suggests a 13.8% upside from the Oct 30 close of $514.24. Recent analyst targets for Linde range from $545 to $591.

Original reporting
Published Oct 31, 2026, 1:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 31, 2026, 2:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains Linde at Buy, raises price target to $585 from $574 — source image
Decision brief

The 30-second read

$LINBullishLow
01

Why it matters

The upgrade may attract short-term interest but lacks a catalyst for a strong move.

02

Market read

Analyst target raise provides modest upside potential for LIN.

03

What to watch

No new earnings or contract news; upgrade based on analyst opinion alone.

Relevance 5/10Novelty 5/10Timing: today

Background

UBS maintains a Buy rating on Linde and adjusts its price target upward.

Company-level read

Ticker impact

$LINBullishMedium confidence
Context

UBS raised its price target for Linde to $585 from $574, indicating a fresh analyst upgrade.

Expected impact

potential modest upside as investors price in higher target

Evidence & confidence

The target raise suggests improved outlook, but no new corporate event drives a large move.

Market effects

May slightly lift industrial gases sector sentiment.

Limited to markets tracking Linde and related peers.

Low global impact.

Counterpoint

Target raise could be premature if broader market conditions weaken.

Key entities

  • Linde plc

    Industrial gases producer.

  • UBS

    Issued the price target raise.

Related articles

$LINMedAI 8/10

Linde PLC (LIN) (Q3 2026) Earnings Call Highlights: Record Sales, Profit and EPS

Linde PLC (LIN) reported Q3 2026 record sales, profit, and EPS, but faced challenges in non-gas segments like Lincare, which reduced EPS growth by 2%. Q4 EPS guidance is $4.40-$4.50, a 3% sequential decline due to FX headwinds and seasonality. Europe and China markets remain weak. Management is evaluating strategic options for Lincare and expects no near-term recovery in Europe or China. Electronics growth is strong, supported by $2B in projects.

$LINMed

Linde plc Q3 2026 Earnings Call Summary

Linde plc reported Q3 2026 earnings, including a $425M restructuring charge. Lincare was moved to the Global Other segment. Chemicals and Energy grew 12%, Electronics 15%. Q4 EPS guidance is $4.40-$4.50. Management expects restructuring benefits by H2 2027 and Woodside ammonia project completion by H1 2027.

$LINMedAI 8/10

Linde Q3 Earnings Call Highlights

Linde (LIN) reported varied demand across regions and sectors in Q3, with electronics sales up 15% and chemicals/energy up 12%. U.S. packaged-gas growth remained in the low teens, while Europe saw flat market conditions. Linde's project backlog is near $8 billion, with the Woodside project expected to contribute financially in 2024. The company forecasted Q4 EPS of $4.40-$4.50, with full-year EPS at $17.82-$17.92.

$LINHighAI 8/10

Linde delivers a good quarter and puts in a fix for an overhang on the stock

Linde reported record Q3 revenue of $9.4B, up 9.2%, and adjusted EPS of $4.59, beating estimates. Shares fell 1% despite strong results due to light Q4 guidance. CEO addressed Lincare restructuring, taking a $425M charge. Sales grew in electronics, chemicals, and energy, with space propellant demand noted. Full-year EPS outlook raised to $17.87, in line with consensus. Linde maintains a $550 price target.